On January 20, 2017, President Donald Trump initiated his second term with executive actions that reshaped U.S. global health policy, including restrictions on foreign aid, reorganization of the Department of State, and expanded application of the Global Gag Rule. According to the Kaiser Family Foundation (KFF), these measures marked a significant shift in how the U.S. funded and managed international health programs. The policies, which sparked debate over their long-term impacts on global public health, were part of a broader strategy to prioritize domestic interests over international commitments.
What Executive Actions Did Trump Take on Global Health?
Trump’s administration implemented several executive orders affecting global health funding. On his first day, he reinstated and expanded the Mexico City Policy, also known as the Global Gag Rule, which prohibits U.S. funding for international organizations that provide or advocate for abortion services. This policy, according to the KFF, impacted over 300 groups worldwide, including those focused on maternal health and HIV/AIDS prevention. Additionally, the administration proposed freezing non-defense foreign aid, though Congress later restored most funding through appropriations bills.
The Department of State underwent reorganization under Secretary Rex Tillerson, with some functions transferred to the Department of Health and Human Services. However, the U.S. Agency for International Development (USAID), which manages most global health programs, remained operational. A 2018 report by the Congressional Research Service noted that while USAID’s budget faced pressure, its core missions, including malaria and HIV programs, continued with adjusted priorities.
How Did These Policies Affect Global Health Programs?
The expanded Global Gag Rule led to concerns about reduced access to reproductive health services in low-income countries. A 2019 study published in The Lancet estimated that the policy could result in 340,000 additional unintended pregnancies and 10,000 maternal deaths annually in affected regions. Meanwhile, the administration’s focus on bilateral aid over multilateral organizations like the Global Fund to Fight AIDS, Tuberculosis and Malaria shifted funding priorities, according to the Center for Global Development.
Despite these changes, USAID maintained its role in global health. In 2018, the agency allocated $2.6 billion to HIV/AIDS programs, $1.3 billion to malaria, and $750 million to maternal and child health, per the U.S. Government Accountability Office (GAO). However, advocates argue that the emphasis on anti-abortion policies limited the scope of services available through U.S.-funded programs.
What Were the Long-Term Implications of These Actions?
The policies reflected a broader ideological shift toward restricting U.S. international aid to align with conservative values. This approach contrasted with previous administrations, which had expanded global health initiatives under Presidents Barack Obama and George W. Bush. The Trump-era changes were partially reversed under President Joe Biden, who lifted the Global Gag Rule in his first week in office, according to the White House.
Experts warn that such policy shifts can disrupt long-term public health efforts. “Funding fluctuations and ideological constraints create uncertainty for global health partners,” said Dr. Sarah Ali, a global health policy analyst at the Brookings Institution. “Sustained investment is critical for addressing epidemics and achieving health equity.”
As of 2023, the U.S. remains the largest donor to global health initiatives, but the legacy of Trump’s policies underscores the vulnerability of international health programs to political changes. Ongoing debates about the role of foreign aid and the balance between domestic and global priorities will likely shape future U.S. health policies.